Table 4.

Frequency of the NQO1 Polymorphism in 45 Primary and Therapy-Related Myeloid Leukemia Patients With Clonal Abnormalities of Chromosomes 5 and/or 7

NQO1 Genes No. Observed (%) No. Expected (%)P
2 Wild-type alleles  21 (47)  27.58 (61) 
Heterozygous  17 (38)  15.25 (34)  .002  
Homozygous 7 (16)  2.16 (5) 
NQO1 Genes No. Observed (%) No. Expected (%)P
2 Wild-type alleles  21 (47)  27.58 (61) 
Heterozygous  17 (38)  15.25 (34)  .002  
Homozygous 7 (16)  2.16 (5) 

The observed frequency of the mutant allele (0.34) was increased approximately 1.6-fold within this group of 45 patients (P = .002). Among 33 patients with balanced translocations, the mutant allele frequency was 0.23, approximately what would be expected.

or Create an Account

Close Modal
Close Modal